IFRX

InflaRx NV News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
InflaRx NV IFRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.33 -7.35% 4.16 19:55:52
Open Price Low Price High Price Close Price Prev Close
4.50 4.14 4.56 4.15 4.49
more quote information »

Recent News

Date Time Source Heading
2/26/202117:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/25/202108:47SEEKInflaRx prices $75M capital raise
2/25/202108:30GLOBEInflaRx Announces Pricing of $75 Million Public Offering of..
2/24/202117:23EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/24/202116:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/24/202116:06SEEKInflaRx launches stock offering
2/24/202116:01GLOBEInflaRx Announces Proposed Offering of Common Shares and..
2/16/202117:05EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202107:30GLOBEInflaRx Announces Presentation of New C5a and Vilobelimab..
1/11/202107:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/11/202107:30GLOBEInflaRx Provides Update on Vilobelimab (IFX-1) Development
1/07/202107:30GLOBEInflaRx to Present at Upcoming Annual J.P. Morgan Healthcare..
1/05/202107:50EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/05/202107:30GLOBEInflaRx Completes Enrollment in Vilobelimab (IFX-1) European..
9/17/202007:31EDGARReport of Foreign Issuer (6-k)
9/17/202007:30GLOBEInflaRx Announces Leadership Team Additions with New CFO and..
9/14/202007:36EDGARReport of Foreign Issuer (6-k)
9/14/202007:30GLOBEInflaRx Announces Initiation of Phase III Part of Phase..
8/06/202007:35EDGARReport of Foreign Issuer (6-k)
8/06/202007:30GLOBEInflaRx to Present at Upcoming Virtual Investor Events
7/30/202008:40EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/30/202007:37EDGARReport of Foreign Issuer (6-k)
7/30/202007:30GLOBEInflaRx Reports Q2 2020 Financial & Operating Results
7/21/202007:36EDGARReport of Foreign Issuer (6-k)
7/21/202007:30GLOBEInflaRx Announces Decision to Enter Phase III Development of..
7/20/202009:22EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/20/202009:03EDGARReport of Foreign Issuer (6-k)
7/20/202006:02EDGARNotice of Effectiveness (effect)
7/16/202016:06EDGARReport of Foreign Issuer (6-k)
7/16/202009:34EDGARSecurities Registration (foreign Private Issuer) (f-3/a)
7/08/202017:00EDGARSecurities Registration (foreign Private Issuer) (f-3)
6/30/202007:02EDGARReport of Foreign Issuer (6-k)
6/17/202007:31EDGARReport of Foreign Issuer (6-k)
6/17/202007:30GLOBEInflaRx Reports Encouraging Topline Results from the..
5/21/202008:10EDGARReport of Foreign Issuer (6-k)
5/21/202007:30GLOBEInflaRx Reports Q1 2020 Financial & Operating Results
4/29/202016:56EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
4/29/202008:01EDGARReport of Foreign Issuer (6-k)
4/29/202008:00GLOBEInflaRx Reports Full Year 2019 Financial & Operating Results
4/09/202007:27EDGARReport of Foreign Issuer (6-k)
4/01/202006:03EDGARReport of Foreign Issuer (6-k)
3/31/202016:15GLOBEInflaRx Doses First Patient in Multicenter Randomized..
3/02/202016:06EDGARReport of Foreign Issuer (6-k)
See more news about this stock »


Your Recent History
NASDAQ
IFRX
InflaRx NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.